| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 24.34▼ | 24.30▲ | 24.29▲ | 24.19▲ | 25.21▼ |
| MA10 | 24.34▼ | 24.30▲ | 24.17▲ | 24.37▼ | 25.55▼ |
| MA20 | 24.31▲ | 24.15▲ | 24.10▲ | 25.13▼ | 26.36▼ |
| MA50 | 24.29▲ | 24.14▲ | 24.14▲ | 25.71▼ | 25.68▼ |
| MA100 | 24.21▲ | 24.20▲ | 24.92▼ | 26.48▼ | 25.84▼ |
| MA200 | 24.12▲ | 25.01▼ | 25.38▼ | 25.87▼ | 30.87▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.014▲ | 0.050▲ | -0.100▼ | -0.315▼ |
| RSI | 50.548▲ | 56.273▲ | 55.457▲ | 39.779▼ | 38.937▼ |
| STOCH | 62.605 | 36.027 | 68.496 | 20.908 | 23.849 |
| WILL %R | -48.571 | -32.075 | -31.098 | -75.610▼ | -86.341▼ |
| CCI | -15.808 | 35.376 | 68.849 | -50.027 | -156.509▼ |
|
Thursday, July 02, 2026 07:57 AM
Pfizer’s valuation story turns to pipeline progress, oncology pressure, earnings strength, and healthcare execution after a difficult market stretch.
|
|
Thursday, July 02, 2026 07:57 AM
Pfizer’s valuation story turns to pipeline progress, oncology pressure, earnings strength, and healthcare execution after a difficult market stretch.
|
|
Wednesday, July 01, 2026 08:00 AM
These stocks offer high yields, are big names in their respective sectors, and have strong fundamentals.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/07/26 | 24.15 | 24.57 | 24.13 | 24.32 | 51,809,215 |
| 01/07/26 | 24.15 | 24.24 | 23.74 | 23.88 | 49,238,836 |
| 30/06/26 | 24.43 | 24.455 | 23.78 | 24.08 | 46,411,485 |
| 29/06/26 | 24.29 | 24.50 | 24.10 | 24.37 | 46,147,517 |
| 26/06/26 | 23.74 | 24.35 | 23.74 | 24.29 | 36,033,387 |
| 25/06/26 | 24.19 | 24.3369 | 23.62 | 23.67 | 48,843,096 |
| 24/06/26 | 24.795 | 25.11 | 23.925 | 24.04 | 75,223,623 |
| 23/06/26 | 24.99 | 25.235 | 24.69 | 24.72 | 81,943,195 |
| 22/06/26 | 25.22 | 25.305 | 24.96 | 25.08 | 39,942,242 |
| 18/06/26 | 25.581 | 25.66 | 24.94 | 25.21 | 67,907,094 |
|
|
||||
|
|
||||
|
|